This is owing to improvements in treatment leading
to increased life expectancy of people with hereditary conditions, like sickle cell disease and
hemophilia, but also the rising occurrence of risk factors for venous thromboembolism. The lack of
adequate surveillance systems to monitor these conditions and their associated health indicators is
a significant barrier to successfully assess, inform, and measure prevention efforts and progress
toward national health goals.